Anti-Cancer Agents in Medicinal Chemistry, Volume 12 - Number 7

PREFACE [Hot Topic: Novel Cancer-Targeting Agents/Application Strategies Developed from MMP Science]

, 12(7): 687

Isao Okazaki

DOI: 10.2174/187152012802650282

Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream

, 12(7): 688 - 706

Isao Okazaki and Kazuki Nabeshima

DOI: 10.2174/187152012802650200

Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment

, 12(7): 707 - 717

Dimitris Stellas and Evangelia Patsavoudi

DOI: 10.2174/187152012802650246

RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)

, 12(7): 718 - 725

Siddavaram Nagini

DOI: 10.2174/187152012802650237

Modulation of MMPs by Cell Surface Integrin Receptor α5β1

, 12(7): 726 - 732

Sekhar Pal, Kirat Kumar Ganguly, Shuvojit Moulik and Amitava Chatterjee

DOI: 10.2174/187152012802650183

MicroRNAs in Cancer: Small Molecules, Big Chances

, 12(7): 733 - 743

Mohammed Abba, Giridhar Mudduluru and Heike Allgayer

DOI: 10.2174/187152012802650273

Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers

, 12(7): 744 - 752

Yasuhiro Hida and Jun-ichi Hamada

DOI: 10.2174/187152012802650156

Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science

, 12(7): 753 - 763

Isao Okazaki and Yutaka Inagaki

DOI: 10.2174/187152012802650165

MMPs in Ovarian Cancer as Therapeutic Targets

, 12(7): 764 - 772

Amer Karam and Oliver Dorigo

DOI: 10.2174/187152012802650174

Regulation of MMPs During Melanoma Progression: From Genetic to Epigenetic

, 12(7): 773 - 782

Frank Antonicelli, David Vallerand, Aurélie Trussardi-Regnier, Florent Grange, William Hornebeck and Philippe Bernard

DOI: 10.2174/187152012802650228

The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro

, 12(7): 783 - 790

Dhana E. Larsson, Saadia B. Hassan, Kjell Oberg and Dan Granberg

DOI: 10.2174/187152012802650147

A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts

, 12(7): 791 - 800

Koshi Kawakami, Miho Hattori, Takatsugu Inoue, Yuriko Maruyama, Junko Ohkanda, Nobuo Kato, Miki Tongu, Takaya Yamada, Miho Akimoto, Keizo Takenaga, Takeshi Sassa, Junji Suzumiy and Yoshio Honma

DOI: 10.2174/187152012802650264

Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition

, 12(7): 801 - 806

Jean M. Brunel, Chanaz Salmi-Smail, Audrey Restouin, Thomas Prebet, Norbert Vey and Yves Collette

DOI: 10.2174/187152012802650192

Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents

, 12(7): 807 - 817

Andrey A. Toropov, Alla P. Toropova, Emilio Benfenati, Giuseppina Gini, Danuta Leszczynska and Jerzy Leszczynski

DOI: 10.2174/187152012802650255

Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice

, 12(7): 818 - 828

Zhisong Cao, John Mendoza, Anthony Kozielski, Xing Liu, Albert DeJesus, Yang Wang, Chang-Guo Zhan, Dana Vardeman and Beppino Giovanella

DOI: 10.2174/187152012802650219

Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma

, 12(7): 829 - 834

Yoshihiro Yakushijin, Tomiko Tatsukawa, Takumi Yamaguchi, Takashi Egawa, Noriaki Hidaka, Keiko Ido, Katsuya Suemaru, Masaki Yasukawa and Hiroak Araki

DOI: 10.2174/187152012802650138

Webmaster Contact:
Copyright © 2018 Bentham Science